Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine

Seventy-four patients with one to eight proven intraaxial brain metastases received a total cumulative dose of 0.2 mmol/kg bodyweight gadobenate dimeglumine, administered as sequential injections of 0.05, 0.05 and 0.1 m mol/kg over a 20-min period. MR imaging was performed before the first administr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuroradiology 2002-03, Vol.44 (3), p.191-203
Hauptverfasser:	BALERIAUX, D, COLOSIMO, C, BOURNE, M. W, PARIZEL, P. M, CHERRYMAN, G. R, SALERIO, I, LA NOCE, A, PIROVANO, G, KIRCHIN, M. A, SPINAZZI, A, RUSCALLEDA, J, KORVES, M, SCHNEIDER, G, BOHNDORF, K, BONGARTZ, G, VAN BUCHEM, M. A, REISER, M, SARTOR, K
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Brain Neoplasms - diagnosis Brain Neoplasms - secondary Contrast Media Female Gadolinium Humans Magnetic Resonance Imaging Male Medical sciences Meglumine - analogs & derivatives Middle Aged Neurology Organometallic Compounds Prospective Studies Safety Tumors of the nervous system. Phacomatoses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Seventy-four patients with one to eight proven intraaxial brain metastases received a total cumulative dose of 0.2 mmol/kg bodyweight gadobenate dimeglumine, administered as sequential injections of 0.05, 0.05 and 0.1 m mol/kg over a 20-min period. MR imaging was performed before the first administration (T2- and T1-weighted sequences) and after each injection of contrast agent (T1-weighted sequences only). Quantitative assessment of images revealed significant (P
ISSN:	0028-3940 1432-1920
DOI:	10.1007/s002340100636